Dr. Blazing is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4101 N Roxboro St
Durham, NC 27704Phone+1 919-684-8111
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 1991 - 1995
- University of California (San Francisco)Internship, Internal Medicine, 1987 - 1988
- University of California San Francisco School of MedicineClass of 1987
Certifications & Licensure
- CA State Medical License 1989 - Present
- NC State Medical License 1995 - 2025
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 985 citationsRisk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysisDavid Preiss, Sreenivasa Rao Kondapally Seshasai, Paul Welsh, Sabina A. Murphy, Jennifer E. Ho
JAMA. 2011-06-22 - 82 citationsPolyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial.Marc P. Bonaca, J. Antonio Gutierrez, Christopher P. Cannon, Robert P. Giugliano, Michael A. Blazing
The Lancet. Diabetes & Endocrinology. 2018-12-01 - 131 citationsAtherothrombotic Risk Stratification and Ezetimibe for Secondary PreventionErin A. Bohula, David A. Morrow, Robert P. Giugliano, Michael A. Blazing, Ping He
Journal of the American College of Cardiology. 2017-02-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: